The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

30 Dec 2020 12:38

RNS Number : 1668K
ADVFN PLC
30 December 2020
 

For immediate release 

30 December 2020

ADVFN PLC

("ADVFN" or the "Company")

Director / PDMR shareholding

 

The Board of ADVFN PLC announces that the Board has agreed to amend the terms of 1,222,946 options held by certain directors, in aggregate representing 4.76 per cent. of the issued share capital of the Company. The exercise price of the options has been re-set at 14p per new ordinary share (compared to a closing mid-market price of 11.5p on 29 December 2020). Prior to the amendment, the options had exercise prices substantially greater than the prevailing market price.

The table below sets out the amended options:

Director

Original grant date

M Hodges

C Chambers

 J Mullins

M Collom

Pre-amendment exercise price per share

Amended exercise price per share

27.01.04

40,000

60,000

40,000

0

118.75p

14p

27.01.05

40,000

60,000

40,000

0

115p

14p

06.09.06

60,000

60,000

60,000

0

82.5p

14p

21.10.09

31,473

31,473

0

0

76.4p

14p

12.12.14

200,000

200,000

100,000

200,000

79.5p

14p

The re-setting of the option exercise price was reviewed by the independent non-executive director of the Company, Mr Tom Spiller and approved on 29 December 2020. Other than an amendment to the exercise price, the terms of the options remain unaltered. Other than the options granted in 2014 (which lapse on 12 December 2024), the options set out in the table above will lapse unless exercised on or before 31 December 2022. No other options have been issued or amended in the prior 12-month period.

A copy of this announcement is available on the Company's website, at www.advfn.com

For further information please contact:

ADVFN PLC

Clem Chambers CEO

Tel: +44 20 3868 6702

 

 

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

Roland Cornish/Michael Cornish

Tel: +44 (0) 207 628 3396

 

Cassiopeia Ltd (Investor Relations)

Stefania Barbaglio

stefania@cassiopeia-ltd.com

 The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. Michael Hodges

2. Clem Chambers

3. Jonathan Mullins

4. Matthew Collom

2

 

Reason for the notification

 

a)

 

Position/

status

 

 

1. Chairman

2. Chief Executive

3. Director

4. Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

ADVFN plc

b)

 

LEI

 

21380042SDV1E1ZVIY40

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.2p each ("Ordinary Shares")

Identification code

GB00BPT24C10

 

b)

 

Nature of the transaction

Amendment of exercise price of options over Ordinary Shares

c)

 

Price(s) and volume(s)

Director

Price payable on exercise of option

Volume(s)

 

Michael Hodges

£0.14

371,473

Clem Chambers

£0.14

411,473

Jonathan Mullins

£0.14

240,000

Matthew Collom

£0.14

200,000

d)

 

Aggregated information

- Aggregated volume

1,222,946 options over Ordinary Shares

- Price

Price payable on exercise of option - UK£0.14

e)

 

Date of the transaction

 

29 December 2020

f)

 

Place of the transaction

 

Outside a trading venue

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLBLFXBLLFFBK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.